News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
74,596 Results
Type
Article (1922)
Company Profile (4)
Press Release (72670)
Section
Business (25420)
Career Advice (9)
Deals (4571)
Drug Development (8161)
FDA (1811)
Job Trends (799)
News (37118)
Policy (3565)
Tag
2027 BioCapital Standard (1)
Academia (103)
Accelerated approval (5)
ADA (2)
Allergies (27)
Alliances (8172)
ALS (23)
Alzheimer's disease (196)
Antibody-drug conjugate (ADC) (148)
Approvals (2009)
Artificial intelligence (43)
ASCO (37)
Autoimmune disease (45)
Automation (3)
Bankruptcy (10)
Best Places to Work (584)
BIO (12)
Biologics (10)
Biosimilars (109)
BioSpace Insights (1)
Biotechnology (5)
Bispecific (10)
Bladder cancer (35)
Brain cancer (8)
Breast cancer (70)
Cancer (737)
Cardiovascular disease (34)
Career advice (9)
CAR-T (20)
CDC (2)
CDMO (14)
Celiac Disease (1)
Cell therapy (70)
Cervical cancer (5)
Clinical research (7886)
Collaboration (370)
Commercialization (18)
Compensation (38)
Complete response letters (8)
COVID-19 (204)
CRISPR (1)
C-suite (121)
Cystic fibrosis (9)
Data (1030)
Depression (18)
Dermatology (22)
Diabetes (56)
Diagnostics (664)
Digital health (8)
Drug discovery (48)
Drug pricing (1)
Duchenne muscular dystrophy (53)
Earnings (8416)
ESMO (50)
Events (7810)
Executive appointments (82)
Eye disease (2)
FDA (2408)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (174)
Gene editing (7)
Generative AI (1)
Gene therapy (47)
GLP-1 (88)
Government (246)
Grass and pollen (1)
Guidances (41)
Healthcare (1167)
Hematology (18)
HIV (7)
Huntington's disease (3)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (31)
Immunology and inflammation (8)
Immuno-oncology (15)
Indications (36)
Infectious disease (234)
Inflammatory bowel disease (27)
Inflation Reduction Act (1)
Influenza (15)
Intellectual property (46)
IPO (1659)
Job creations (241)
Job search strategy (9)
JPM (3)
Kidney cancer (2)
Kidney disease (14)
Layoffs (6)
Legal (953)
Licensing (35)
Liver cancer (23)
Longevity (3)
Lung cancer (142)
Lung diease (3)
Lymphoma (64)
Machine learning (1)
Manufacturing (166)
Marketing (10)
MASH (20)
Medical device (1185)
Medtech (1208)
Mergers & acquisitions (3137)
Metabolic disorders (136)
mRNA (11)
Multiple sclerosis (31)
NASH (1)
Neurodegenerative disease (39)
Neuropsychiatric disorders (7)
Neuroscience (388)
NextGen: Class of 2026 (218)
Non-profit (64)
Obesity (47)
Opinion (1)
Ovarian cancer (38)
Pain (24)
Pancreatic cancer (35)
Parkinson's disease (54)
Partnered (4)
Patents (82)
Patient recruitment (95)
Patient selection (20)
Peanut (2)
People (5282)
Peptides (2)
Pharmaceutical (2)
Pharmacy benefit managers (5)
Phase 1 (2123)
Phase 2 (3351)
Phase 3 (2986)
Pipeline (1676)
Policy (1)
Postmarket research (241)
Preclinical (718)
Press Release (2)
Prostate cancer (31)
Radiopharmaceuticals (31)
Rare diseases (104)
Real estate (608)
Regenerative medicine (7)
Regulatory (3173)
Reports (11)
Research institute (98)
Rett syndrome (1)
RNA editing (3)
RSV (3)
Schizophrenia (28)
Series A (39)
Series B (25)
Service/supplier (1)
Sickle cell disease (9)
Spinal muscular atrophy (5)
Sponsored (1)
Startups (425)
Stomach cancer (2)
Substance use disorders (2)
Supply chain (15)
Switzerland (8)
Vaccines (52)
Venture capital (7)
Weight loss (22)
Women's health (10)
Date
Today (17)
Last 7 days (84)
Last 30 days (351)
Last 365 days (2958)
2026 (2634)
2025 (2704)
2024 (3267)
2023 (3827)
2022 (7011)
2021 (6393)
2020 (5890)
2019 (3863)
2018 (3010)
2017 (3579)
2016 (3191)
2015 (4046)
2014 (3032)
2013 (2627)
2012 (2784)
2011 (2909)
2010 (2664)
Location
Africa (89)
Alabama (5)
Arizona (15)
Arkansas (1)
Asia (22604)
Australia (2506)
California (950)
Canada (530)
China (611)
Colorado (6)
Connecticut (31)
Delaware (9)
Europe (13707)
Florida (149)
Georgia (18)
Hawaii (1)
Illinois (51)
India (71)
Indiana (38)
Japan (399)
Kansas (5)
Louisiana (2)
Maine (4)
Maryland (143)
Massachusetts (753)
Michigan (9)
Minnesota (42)
Missouri (3)
Nebraska (3)
Nevada (16)
New Hampshire (1)
New Jersey (597)
New York (313)
North Carolina (143)
Northern California (417)
Ohio (9)
Oregon (1)
Pennsylvania (182)
Puerto Rico (1)
Rhode Island (1)
South America (109)
South Carolina (1)
Southern California (464)
Tennessee (6)
Texas (74)
United States (3678)
Utah (39)
Vermont (1)
Virginia (74)
Washington D.C. (3)
Washington State (68)
Wisconsin (9)
Wyoming (1)
74,596 Results for "inspiremd ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
InspireMD Reports Third Quarter 2026 Financial Results
November 12, 2026
·
16 min read
Press Releases
InspireMD to Announce Third Quarter 2026 Financial Results
October 29, 2026
·
1 min read
Press Releases
InspireMD Announces Pricing of $37.5 Million Public Offering
November 13, 2026
·
8 min read
Press Releases
InspireMD Announces Updated Timing for Third Quarter 2026 Financial Results
November 11, 2026
·
1 min read
Press Releases
InspireMD Announces FDA Approval of the CGuard® Prime TransCarotid Stent System for Transcarotid Artery Revascularization (TCAR) Procedures
November 12, 2026
·
10 min read
Press Releases
InspireMD to Announce Second Quarter 2026 Financial Results
August 10, 2026
·
1 min read
Press Releases
InspireMD Reports Second Quarter 2026 Financial Results
August 17, 2026
·
18 min read
Press Releases
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - September 4, 2026
September 6, 2026
·
6 min read
Press Releases
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 7, 2026
August 9, 2026
·
6 min read
Press Releases
InspireMD to Announce First Quarter 2026 Financial Results
April 28, 2026
·
1 min read
1 of 7,460
Next